# Aviat Networks, Inc.: financial statements, quarterly

AVNW · Nasdaq · CIK 1377789 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/avnw.md) · [Financials](/companies/avnw/financials.md) · [Filings](/companies/avnw/filings.md) · [Insiders](/companies/avnw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/avnw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-29) | Q2 FY2024 (2023-12-29) | Q3 FY2024 (2024-03-29) | Q4 FY2024 (2024-06-28) | Q1 FY2025 (2024-09-27) | Q2 FY2025 (2024-12-27) | Q3 FY2025 (2025-03-28) | Q4 FY2025 (2025-06-27) | Q1 FY2026 (2025-09-26) | Q2 FY2026 (2025-12-26) | Q3 FY2026 (2026-03-27) | Q4 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [86.9](/filings/0001377789-24-000058.md) | [93.7](/filings/0001377789-25-000007.md) | [111](/filings/0001377789-25-000016.md) | [117 d](/filings/0001628280-26-059187.md) | [88.4](/filings/0001377789-25-000106.md) | [118](/filings/0001628280-26-005015.md) | [113](/filings/0001628280-26-029810.md) | [115 d](/filings/0001628280-26-059187.md) | [107](/filings/0001377789-25-000106.md) | [111](/filings/0001628280-26-005015.md) | [100](/filings/0001628280-26-029810.md) | [121 d](/filings/0001628280-26-059187.md) |
| Cost of revenue | $m | [55.7](/filings/0001377789-24-000058.md) | [57.4](/filings/0001377789-25-000007.md) | [74.8](/filings/0001377789-25-000016.md) | [75.5 d](/filings/0001628280-26-059187.md) | [68.6](/filings/0001377789-25-000106.md) | [77.3](/filings/0001628280-26-005015.md) | [73.3](/filings/0001628280-26-029810.md) | [75.9 d](/filings/0001628280-26-059187.md) | [71.7](/filings/0001377789-25-000106.md) | [75.4](/filings/0001628280-26-005015.md) | [70.7](/filings/0001628280-26-029810.md) | [83.6 d](/filings/0001628280-26-059187.md) |
| Gross profit | $m | [31.2](/filings/0001377789-24-000058.md) | [36.3](/filings/0001377789-25-000007.md) | [36.1](/filings/0001377789-25-000016.md) | [41.1 d](/filings/0001628280-26-059187.md) | [19.8](/filings/0001377789-25-000106.md) | [40.9](/filings/0001628280-26-005015.md) | [39.3](/filings/0001628280-26-029810.md) | [39.5 d](/filings/0001628280-26-059187.md) | [35.7](/filings/0001377789-25-000106.md) | [36.1](/filings/0001628280-26-005015.md) | [29.3](/filings/0001628280-26-029810.md) | [37.2 d](/filings/0001628280-26-059187.md) |
| Research and development | $m | [6.4](/filings/0001377789-24-000058.md) | [8.4](/filings/0001377789-25-000007.md) | [10.6](/filings/0001377789-25-000016.md) | [11.0 d](/filings/0001628280-26-059187.md) | [10.4](/filings/0001377789-25-000106.md) | [10.2](/filings/0001628280-26-005015.md) | [7.7](/filings/0001628280-26-029810.md) | [7.4 d](/filings/0001628280-26-059187.md) | [7.1](/filings/0001377789-25-000106.md) | [6.4](/filings/0001628280-26-005015.md) | [7.7](/filings/0001628280-26-029810.md) | [7.2 d](/filings/0001628280-26-059187.md) |
| Selling, general and administrative | $m | [19.2](/filings/0001377789-24-000058.md) | [22.5](/filings/0001377789-25-000007.md) | [20.2](/filings/0001377789-25-000016.md) | [23.1 d](/filings/0001628280-26-059187.md) | [24.9](/filings/0001377789-25-000106.md) | [21.3](/filings/0001628280-26-005015.md) | [22.1](/filings/0001628280-26-029810.md) | [21.1 d](/filings/0001628280-26-059187.md) | [23.4](/filings/0001377789-25-000106.md) | [22.4](/filings/0001628280-26-005015.md) | [20.4](/filings/0001628280-26-029810.md) | [22.4 d](/filings/0001628280-26-059187.md) |
| Operating income | $m | [4.9](/filings/0001377789-24-000058.md) | [3.4](/filings/0001377789-25-000007.md) | [5.7](/filings/0001377789-25-000016.md) | [5.5 d](/filings/0001628280-26-059187.md) | [(15.6)](/filings/0001377789-25-000106.md) | [8.0](/filings/0001628280-26-005015.md) | [9.3](/filings/0001628280-26-029810.md) | [8.9 d](/filings/0001628280-26-059187.md) | [5.2](/filings/0001377789-25-000106.md) | [7.3](/filings/0001628280-26-005015.md) | [0.9](/filings/0001628280-26-029810.md) | [5.8 d](/filings/0001628280-26-059187.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.4](/filings/0001377789-24-000058.md) | [1.8](/filings/0001377789-25-000007.md) | [0.8](/filings/0001377789-25-000016.md) | [3.1 d](/filings/0001628280-26-059187.md) | [(5.5)](/filings/0001377789-25-000106.md) | [1.6](/filings/0001628280-26-005015.md) | [1.1](/filings/0001628280-26-029810.md) | [5.0 d](/filings/0001628280-26-059187.md) | [2.3](/filings/0001377789-25-000106.md) | [2.4](/filings/0001628280-26-005015.md) | [(0.2)](/filings/0001628280-26-029810.md) | [6.2 d](/filings/0001628280-26-059187.md) |
| Net income | $m | [3.6](/filings/0001377789-24-000058.md) | [1.8](/filings/0001377789-25-000007.md) | [3.9](/filings/0001377789-25-000016.md) | [1.5 d](/filings/0001628280-26-059187.md) | [(11.9)](/filings/0001377789-25-000106.md) | [4.5](/filings/0001628280-26-005015.md) | [3.5](/filings/0001628280-26-029810.md) | [5.2 d](/filings/0001628280-26-059187.md) | [0.2](/filings/0001377789-25-000106.md) | [5.7](/filings/0001628280-26-005015.md) | [(2.1)](/filings/0001628280-26-029810.md) | [(1.3) d](/filings/0001628280-26-059187.md) |
| Diluted EPS | $ per share | [0.30](/filings/0001377789-24-000058.md) | [0.15](/filings/0001377789-25-000007.md) | [0.30](/filings/0001377789-25-000016.md) | not reported | [(0.94)](/filings/0001377789-25-000106.md) | [0.35](/filings/0001628280-26-005015.md) | [0.27](/filings/0001628280-26-029810.md) | not reported | [0.01](/filings/0001377789-25-000106.md) | [0.44](/filings/0001628280-26-005015.md) | [(0.16)](/filings/0001628280-26-029810.md) | not reported |
| Basic EPS | $ per share | [0.31](/filings/0001377789-24-000058.md) | [0.15](/filings/0001377789-25-000007.md) | [0.31](/filings/0001377789-25-000016.md) | not reported | [(0.94)](/filings/0001377789-25-000106.md) | [0.35](/filings/0001628280-26-005015.md) | [0.28](/filings/0001628280-26-029810.md) | not reported | [0.01](/filings/0001377789-25-000106.md) | [0.44](/filings/0001628280-26-005015.md) | [(0.16)](/filings/0001628280-26-029810.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-29) | Q2 FY2024 (2023-12-29) | Q3 FY2024 (2024-03-29) | FY2024 (2024-06-28) | Q1 FY2025 (2024-09-27) | Q2 FY2025 (2024-12-27) | Q3 FY2025 (2025-03-28) | FY2025 (2025-06-27) | Q1 FY2026 (2025-09-26) | Q2 FY2026 (2025-12-26) | Q3 FY2026 (2026-03-27) | FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [35.5](/filings/0001377789-23-000043.md) | [45.9](/filings/0001377789-24-000007.md) | [58.2](/filings/0001377789-24-000019.md) | [64.6](/filings/0001377789-25-000068.md) | [51.0](/filings/0001377789-24-000058.md) | [52.6](/filings/0001377789-25-000007.md) | [49.4](/filings/0001377789-25-000016.md) | [59.7](/filings/0001628280-26-059187.md) | [64.8](/filings/0001377789-25-000106.md) | [86.5](/filings/0001628280-26-005015.md) | [78.1](/filings/0001628280-26-029810.md) | [72.8](/filings/0001628280-26-059187.md) |
| Current assets | $m | [244](/filings/0001377789-23-000043.md) | [367](/filings/0001377789-24-000007.md) | [362](/filings/0001377789-24-000019.md) | [405](/filings/0001377789-25-000068.md) | [427](/filings/0001377789-24-000058.md) | [423](/filings/0001377789-25-000007.md) | [457](/filings/0001377789-25-000016.md) | [464](/filings/0001628280-26-059187.md) | [475](/filings/0001377789-25-000106.md) | [494](/filings/0001628280-26-005015.md) | [450](/filings/0001628280-26-029810.md) | [439](/filings/0001628280-26-059187.md) |
| Total assets | $m | [370](/filings/0001377789-23-000043.md) | [500](/filings/0001377789-24-000007.md) | [490](/filings/0001377789-24-000019.md) | [535](/filings/0001377789-25-000068.md) | [591](/filings/0001377789-24-000058.md) | [594](/filings/0001377789-25-000007.md) | [628](/filings/0001377789-25-000016.md) | [633](/filings/0001628280-26-059187.md) | [643](/filings/0001377789-25-000106.md) | [659](/filings/0001628280-26-005015.md) | [617](/filings/0001628280-26-029810.md) | [599](/filings/0001628280-26-059187.md) |
| Current liabilities | $m | [129](/filings/0001377789-23-000043.md) | [184](/filings/0001377789-24-000007.md) | [171](/filings/0001377789-24-000019.md) | [219](/filings/0001377789-25-000068.md) | [248](/filings/0001377789-24-000058.md) | [252](/filings/0001377789-25-000007.md) | [282](/filings/0001377789-25-000016.md) | [282](/filings/0001628280-26-059187.md) | [258](/filings/0001377789-25-000106.md) | [267](/filings/0001628280-26-005015.md) | [226](/filings/0001628280-26-029810.md) | [223](/filings/0001628280-26-059187.md) |
| Total liabilities | $m | [144](/filings/0001377789-23-000043.md) | [246](/filings/0001377789-24-000007.md) | [232](/filings/0001377789-24-000019.md) | [279](/filings/0001377789-25-000068.md) | [344](/filings/0001377789-24-000058.md) | [345](/filings/0001377789-25-000007.md) | [372](/filings/0001377789-25-000016.md) | [370](/filings/0001628280-26-059187.md) | [380](/filings/0001377789-25-000106.md) | [388](/filings/0001628280-26-005015.md) | [345](/filings/0001628280-26-029810.md) | [332](/filings/0001628280-26-059187.md) |
| Long-term debt | $m | not reported | [47.2](/filings/0001377789-24-000007.md) | [46.6](/filings/0001377789-24-000019.md) | [46.0](/filings/0001377789-25-000068.md) | [81.0](/filings/0001377789-24-000058.md) | [71.1](/filings/0001377789-25-000007.md) | [70.2](/filings/0001377789-25-000016.md) | [69.0](/filings/0001628280-26-059187.md) | [102](/filings/0001377789-25-000106.md) | [101](/filings/0001628280-26-005015.md) | [98.7](/filings/0001628280-26-029810.md) | [89.1](/filings/0001628280-26-059187.md) |
| Current portion of debt | $m | not reported | [2.4](/filings/0001377789-24-000007.md) | [2.4](/filings/0001377789-24-000019.md) | [2.4](/filings/0001377789-25-000068.md) | [2.4](/filings/0001377789-24-000058.md) | [3.7](/filings/0001377789-25-000007.md) | [3.7](/filings/0001377789-25-000016.md) | [18.6](/filings/0001628280-26-059187.md) | [4.4](/filings/0001377789-25-000106.md) | [4.4](/filings/0001628280-26-005015.md) | [5.6](/filings/0001628280-26-029810.md) | [7.9](/filings/0001628280-26-059187.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [224](/filings/0001377789-25-000007.md) | [251](/filings/0001377789-25-000016.md) | [256](/filings/0001377789-25-000016.md) | [256](/filings/0001628280-26-059187.md) | [247](/filings/0001628280-26-005015.md) | [250](/filings/0001628280-26-029810.md) | [256](/filings/0001628280-26-029810.md) | [263](/filings/0001628280-26-059187.md) | [264](/filings/0001628280-26-005015.md) | [272](/filings/0001628280-26-029810.md) | [272](/filings/0001628280-26-029810.md) | [267](/filings/0001628280-26-059187.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-29) | Q2 FY2024 (2023-12-29) | Q3 FY2024 (2024-03-29) | Q4 FY2024 (2024-06-28) | Q1 FY2025 (2024-09-27) | Q2 FY2025 (2024-12-27) | Q3 FY2025 (2025-03-28) | Q4 FY2025 (2025-06-27) | Q1 FY2026 (2025-09-26) | Q2 FY2026 (2025-12-26) | Q3 FY2026 (2026-03-27) | Q4 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [14.0](/filings/0001377789-24-000058.md) | [(7.1) d](/filings/0001377789-25-000007.md) | [15.3 d](/filings/0001377789-25-000016.md) | [8.3 d](/filings/0001628280-26-059187.md) | [(27.2)](/filings/0001377789-25-000106.md) | [20.8 d](/filings/0001628280-26-005015.md) | [1.6 d](/filings/0001628280-26-029810.md) | [10.5 d](/filings/0001628280-26-059187.md) | [(11.7)](/filings/0001377789-25-000106.md) | [23.9 d](/filings/0001628280-26-005015.md) | [(1.7) d](/filings/0001628280-26-029810.md) | [3.1 d](/filings/0001628280-26-059187.md) |
| Capital expenditure | $m | [0.7](/filings/0001377789-24-000058.md) | [0.7 d](/filings/0001377789-25-000007.md) | [0.5 d](/filings/0001377789-25-000016.md) | [0.8 d](/filings/0001628280-26-059187.md) | [5.4](/filings/0001377789-25-000106.md) | [2.5 d](/filings/0001628280-26-005015.md) | [2.8 d](/filings/0001628280-26-029810.md) | [2.3 d](/filings/0001628280-26-059187.md) | [1.7](/filings/0001377789-25-000106.md) | [1.4 d](/filings/0001628280-26-005015.md) | [3.7 d](/filings/0001628280-26-029810.md) | [0.6 d](/filings/0001628280-26-059187.md) |
| Share repurchases | $m | not reported | not reported | [0.0 d](/filings/0001377789-24-000019.md) | not reported | not reported | not reported | [0.1 d](/filings/0001628280-26-029810.md) | not reported | not reported | not reported | [0.5 d](/filings/0001628280-26-029810.md) | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-30) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-29) | Q2 FY2024 (2023-12-29) | Q3 FY2024 (2024-03-29) | Q1 FY2025 (2024-09-27) | Q2 FY2025 (2024-12-27) | Q3 FY2025 (2025-03-28) | Q1 FY2026 (2025-09-26) | Q2 FY2026 (2025-12-26) | Q3 FY2026 (2026-03-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.2](/filings/0001377789-23-000043.md) | [11.8](/filings/0001377789-24-000007.md) | [11.9](/filings/0001377789-24-000019.md) | [11.9](/filings/0001377789-24-000058.md) | [12.2](/filings/0001377789-25-000007.md) | [12.8](/filings/0001377789-25-000016.md) | [12.6](/filings/0001377789-25-000106.md) | [12.8](/filings/0001628280-26-005015.md) | [12.8](/filings/0001628280-26-029810.md) | [13.0](/filings/0001377789-25-000106.md) | [13.0](/filings/0001628280-26-005015.md) | [12.9](/filings/0001628280-26-029810.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,801,539 at 2026-08-21, from the cover of the [10-K filed 2026-08-27](/filings/0001628280-26-059187.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.